Crysvita (burosumab)

pCPA File Number: 21235

Negotiation Status:

Concluded with an LOI

Indication(s):

X-Linked Hypophosphatemia

Sponsor/Manufacturer:

Ultragenyx Canada Inc.

CADTH Project Number:

SR0602-000

pCPA Engagement Letter Issued:

2020-10-09

Negotiation Process Concluded:

2021-09-10